Edward Jauch to Tissue Plasminogen Activator
This is a "connection" page, showing publications Edward Jauch has written about Tissue Plasminogen Activator.
Connection Strength
2.594
-
Putting it all together for best stroke practice, all the time. Stroke. 2014 May; 45(5):1243-4.
Score: 0.362
-
Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke. 2006 Oct; 37(10):2508-13.
Score: 0.214
-
Society for Academic Emergency Medicine (SAEM) Neurologic Emergencies Interest Group response to the SAEM Board position on optimizing care of the stroke patient. Acad Emerg Med. 2004 Jan; 11(1):116-8; author reply 118.
Score: 0.178
-
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018 07 10; 320(2):156-166.
Score: 0.121
-
Alteplase for the treatment of acute ischemic stroke in patients with low National Institutes of Health Stroke Scale and not clearly disabling deficits (Potential of rtPA for Ischemic Strokes with Mild Symptoms PRISMS): Rationale and design. Int J Stroke. 2018 08; 13(6):654-661.
Score: 0.119
-
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
Score: 0.112
-
Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke. Circ Cardiovasc Qual Outcomes. 2017 01; 10(1).
Score: 0.109
-
A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaboration. Int J Stroke. 2015 Oct; 10 Suppl A100:136-44.
Score: 0.100
-
Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke. 2014 Dec; 45(12):3606-11.
Score: 0.094
-
Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
Score: 0.091
-
Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation. 2014 Jul 15; 130(3):265-72.
Score: 0.091
-
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 07; 368(10):893-903.
Score: 0.083
-
CT perfusion-guided patient selection for endovascular recanalization in acute ischemic stroke: a multicenter study. J Neurointerv Surg. 2013 Nov; 5(6):523-7.
Score: 0.082
-
Techniques for improving efficiency in the emergency department for patients with acute ischemic stroke. Ann N Y Acad Sci. 2012 Sep; 1268:57-62.
Score: 0.081
-
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke. 2010 Nov; 41(11):2581-6.
Score: 0.070
-
Equipoise among recanalization strategies. Neurology. 2010 Mar 30; 74(13):1069-76.
Score: 0.068
-
Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009 Aug; 40(8):2945-8.
Score: 0.065
-
Thrombolysis 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Dec 25; 359(26):2839; author reply 2841.
Score: 0.063
-
Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008 May; 3(2):130-7.
Score: 0.060
-
Extending the window for acute stroke treatment: thrombolytics plus CNS protective therapies. Exp Neurol. 2004 Aug; 188(2):195-9.
Score: 0.046
-
Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004 Feb; 35(2):e27-9.
Score: 0.045
-
Isoforms of apolipoprotein E can modulate tPA-induced clot lysis in vitro. Front Biosci. 2002 Aug 01; 7:a163-8.
Score: 0.040
-
Emergency stroke management: a new era. Nurs Clin North Am. 2002 Mar; 37(1):35-57, vi.
Score: 0.039
-
Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke. 2000 Nov; 31(11):2552-7.
Score: 0.036
-
Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke. 1999 Nov; 30(11):2366-8.
Score: 0.033
-
Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke. 2015 Dec; 46(12):3416-22.
Score: 0.025
-
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
Score: 0.024
-
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014 Jun; 13(6):567-74.
Score: 0.023
-
Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. J Biopharm Stat. 2013; 23(6):1383-402.
Score: 0.021
-
Four evolving strategies in the emergent treatment of acute ischemic stroke. Emerg Med Pract. 2012 Jul; 14(7):1-26; quiz 26-7.
Score: 0.020
-
Telestroke in South Carolina. J Stroke Cerebrovasc Dis. 2013 Oct; 22(7):946-50.
Score: 0.019
-
Measuring continuous baseline covariate imbalances in clinical trial data. Stat Methods Med Res. 2015 Apr; 24(2):255-72.
Score: 0.019
-
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007 May 22; 115(20):e478-534.
Score: 0.014
-
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007 May; 38(5):1655-711.
Score: 0.014
-
Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab. 2006 Aug; 26(8):1089-102.
Score: 0.013